Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer-Reference-Cited by-同舟云学术

Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer

Published:2022-10 Issue:11 Volume:237 Page:4132-4156
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:Journal Cellular Physiology

Author:

Saravanan Roshni¹,Balasubramanian Vaishnavi¹,Swaroop Balamurugan Srikanth Swamy¹,Ezhil Inemai²,Afnaan Zeba¹,John Jisha¹,Sundaram Sandhya³,Gouthaman Shanmugasundaram⁴,Pakala Suresh B.⁵,Rayala Suresh Kumar²^ORCID,Venkatraman Ganesh¹^ORCID

Affiliation:

1. Department of Human Genetics Sri Ramachandra Faculty of Biomedical Sciences and Technology, Sri Ramachandra Institute of Higher Education and Research Chennai Tamil Nadu India

2. Department of Biotechnology Indian Institute of Technology—Madras Chennai Tamil Nadu India

3. Department of Pathology Sri Ramachandra Medical College and Research Institute, Sri Ramachandra Institute of Higher Education and Research Chennai Tamil Nadu India

4. Department of Surgical Oncology Sri Ramachandra Medical College and Research Institute, Sri Ramachandra Institute of Higher Education and Research Chennai Tamil Nadu India

5. Department of Biochemistry, School of Life Sciences University of Hyderabad Hyderabad Telangana India

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.30880

Reference135 articles.

1. The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line

2. Immunosuppressive activities of adenosine in cancer

3. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer

4. Interrogating differences in expression of targeted gene sets to predict breast cancer outcome;Andres S. A.;BMC Cancer [Internet],2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure;Journal of Cellular Physiology;2024-02-12

2. Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets;Signal Transduction and Targeted Therapy;2024-01-03

3. Emerging treatment approaches for triple-negative breast cancer;Medical Oncology;2023-12-01

4. A Potential Antibody–Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer;Pharmaceutical Fronts;2023-08-24

5. Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer;Breast Cancer: Targets and Therapy;2023-08